Abstract\ud \ud Background\ud \ud Plasmodium vivax is the causative agent of human malaria of large geographic distribution, with 35 million cases annually. In Brazil, it is the most prevalent species, being responsible by around 70 % of the malaria cases.\ud \ud \ud Methods\ud A cross-sectional study was performed in Manaus (Amazonas, Brazil), including 36 adult patients with primary malaria, 19 with recurrent malaria, and 20 endemic controls. The ex vivo phenotypic features of circulating leukocyte subsets (CD4+ T-cells, CD8+ T-cells, NK, NKT, B, B1 and Treg cells) as well as the plasmatic cytokine profile (...
Abstract Background The naturally-acquired immune response to Plasmodium vivax variant antigens (VIR...
Abstract Background ...
Repeated Plasmodium falciparum infections drive the development of clinical immunity to malaria in h...
Abstract\ud \ud Background\ud \ud ...
Abstract Background The mechanisms of activation and regulation of T lymphocytes and their cytokines...
BACKGROUNDThe biology of Plasmodium vivax is markedly different from that of P. falciparum; how this...
Abstract\ud \ud \ud \ud Background\ud ...
BACKGROUND: Despite clinical descriptions of severe vivax malaria cases having been reported, data r...
P. vivax infection is characterised by relapsing fever, indicating reinfection by previously hidden ...
<div><h3>Background</h3><p><em>P. vivax</em> infection is characterised by relapsing fever, indicati...
Homeostatic perturbation caused by infection fosters two major defense strategies, resistance and to...
p. 1-8Background: Despite clinical descriptions of severe vivax malaria cases having been reported, ...
Clearing blood-stage malaria parasites without inducing major host pathology requires a finely tuned...
Background: Plasmodium vivax malaria clinical outcomes are a consequence of the interaction of multi...
Abstract Background The naturally-acquired immune response to Plasmodium vivax variant antigens (VIR...
Abstract Background ...
Repeated Plasmodium falciparum infections drive the development of clinical immunity to malaria in h...
Abstract\ud \ud Background\ud \ud ...
Abstract Background The mechanisms of activation and regulation of T lymphocytes and their cytokines...
BACKGROUNDThe biology of Plasmodium vivax is markedly different from that of P. falciparum; how this...
Abstract\ud \ud \ud \ud Background\ud ...
BACKGROUND: Despite clinical descriptions of severe vivax malaria cases having been reported, data r...
P. vivax infection is characterised by relapsing fever, indicating reinfection by previously hidden ...
<div><h3>Background</h3><p><em>P. vivax</em> infection is characterised by relapsing fever, indicati...
Homeostatic perturbation caused by infection fosters two major defense strategies, resistance and to...
p. 1-8Background: Despite clinical descriptions of severe vivax malaria cases having been reported, ...
Clearing blood-stage malaria parasites without inducing major host pathology requires a finely tuned...
Background: Plasmodium vivax malaria clinical outcomes are a consequence of the interaction of multi...
Abstract Background The naturally-acquired immune response to Plasmodium vivax variant antigens (VIR...
Abstract Background ...
Repeated Plasmodium falciparum infections drive the development of clinical immunity to malaria in h...